Dr Thomas Bachelot
- Spécialité
- Oncologue médical, expert sein et gynécologie
- Titre
- Coordinateur adjoint de département
- Hôpital
- Centre Léon Bérard (Lyon)
- Derniers articles
-
- Erratum: Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay. (10 nov. 2025)
- Machine Learning-Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2- Early Breast Cancer Using Real-World and NATALEE Data. (10 nov. 2025)
- Exceptional responses to Trastuzumab deruxtecan in HER2-positive breast cancer: two illustrative case reports. (22 oct. 2025)
- Prognostic significance and predictive value of circulating tumor cells in invasive lobular breast carcinoma - an exploratory analysis of the STIC CTC trial. (29 sept. 2025)
- Combination of olaparib, durvalumab and fulvestrant in patients with advanced ER+/HER2- breast cancer and selected genomic alterations: results of the DOLAF trial. (23 sept. 2025)